Table: Stella Pharma - 6-MTH parent results

Stella Pharma

08/11/2024 05:01

Nov 8 (Reuters)- 
             Stella Pharma Corporation 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to  
                Sep 30, 2024        Sep 30, 2023      Mar 31, 2025 
                   LATEST             YEAR-AGO           LATEST    
                   RESULTS             RESULTS          FORECAST   
  Sales            169 mln             153 mln          930 mln    
                 (+10.0 pct)         (+66.7 pct)      (+245.1 pct) 
  Operating     loss 269 mln        loss 301 mln      loss 252 mln 
  Recurring     loss 267 mln        loss 303 mln      loss 257 mln 
  Net           loss 268 mln        loss 305 mln      loss 260 mln 
  EPS           loss 8.21 yen       loss 9.95 yen    loss 8.33 yen 
  Ann Div                                NIL              NIL      
  -Q2 div            NIL                 NIL                       
  -Q4 div                                NIL              NIL      
  
  NOTE - Stella Pharma Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4888.T